3D printing of multidrug tablets for breast cancer
The development and testing of personalised, multidrug tablets will be one of the outputs of a new research collaboration between Gustave Roussy and FabRx Ltd, a biotechnology start-up… read more.
The development and testing of personalised, multidrug tablets will be one of the outputs of a new research collaboration between Gustave Roussy and FabRx Ltd, a biotechnology start-up… read more.
The Bone and Joint Journal Early mobilisation after hip fracture surgery has become standard care on the basis of national guidance. The evidence for this is based on… read more.
Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that… read more.
Medulloblastoma is a rare but devastating childhood brain cancer. This cancer can spread through the spinal fluid and be deposited elsewhere in the brain or spine. Radiation therapy… read more.
Repeated tests showed a similar amount of drug release per activation, confirming robust control of release rate. A membrane made from threads of a polymer commonly used in… read more.
Novartis,has announced the FDA has approved Cosentyx (secukinumab) for the treatment of moderate to severe plaque psoriasis in pediatric patients six years and older who are candidates for… read more.
EPFL researchers have developed a device that can continuously measure the blood concentration of propofol – one of the main compounds used in anesthetics – in patients as… read more.
Nearly a quarter of pregnant women say they’ve been around secondhand smoke — in their homes, at work, around a friend or relative — which, according to new… read more.
Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents,… read more.
Interview and article by Christine Clark. Dr Suryakant (Head of the Department of Respiratory Medicine at King George Medical University in Lucknow, India) explains how an ivermectin-based therapy… read more.
Article written by Gary Finnegan. Survival rates among people living with HIV have soared over several decades, thanks to antiretroviral therapies. However, as maintaining long-term treatment can be… read more.
Merck Inc., hosted on 3 May an Organon management investor day meeting, to detail across women’s health, biosimilars and established brands.The new company will be launched on 3… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.